Clinical Trials Insight: 700025917
Phase of Trial: Phase I
Latest Information Update: 04 Mar 2008
At a glance
- Drugs ABT 560 (Primary)
- Indications Cognition disorders; Dementia
- Focus Adverse reactions
- Sponsors Abbott Laboratories
- 04 Mar 2008 Status changed from initiated to recruiting as reported by NeuroSearch.
- 12 Aug 2007 New trial record.